JWH-372
 |
| Legal status |
|
naphthalen-1-yl-[1-pentyl-5-[2-(trifluoromethyl)phenyl]pyrrol-3-yl]methanone
|
| CAS Number |
|
|
PubChem CID
|
|
| ChemSpider |
|
| Formula |
C27H24F3NO
|
| Molar mass |
435.490 g·mol−1
|
| 3D model (JSmol) |
|
CCCCCN1C=C(C=C1C2=CC=CC=C2C(F)(F)F)C(=O)C3=CC=CC4=CC=CC=C43
|
InChI=1S/C27H24F3NO/c1-2-3-8-16-31-18-20(17-25(31)23-13-6-7-15-24(23)27(28,29)30)26(32)22-14-9-11-19-10-4-5-12-21(19)22/h4-7,9-15,17-18H,2-3,8,16H2,1H3 Y
Key:CYPUIQJYGVOHMM-UHFFFAOYSA-N Y
|
JWH-372 (naphthalen-1-yl-[1-pentyl-5-[2-(trifluoromethyl)phenyl]pyrrol-3-yl]methanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as a potent and selective agonist of the CB2 receptor.
JWH-372 binds approximately 9 times stronger to the CB2 receptor (Ki = 8.2 ± 0.2nM) than the CB1 receptor (Ki = 77 ± 2nM). The selectivity of JWH-372 for the CB2 receptor is likely due to the electron-withdrawing character of the trifluoromethyl group rather than steric effects, as the o-methyl compound JWH-370 was only mildly selective for the CB2 receptor (CB1 Ki = 5.6 ± 0.4nM, CB2 Ki = 4.0 ± 0.5nM).
Legality
In the United States JWH-372 is not federally scheduled, although some states have passed legislation banning the sale, possession, and manufacture of JWH-372.
In Canada, JWH-372 and other naphthoylpyrrole-based cannabinoids are Schedule II controlled substances under the Controlled Drugs and Substances Act.
In the United Kingdom, JWH-372 and other naphthoylpyrrole-based cannabinoids are considered Class B drugs under the Misuse of Drugs Act 1971.
See also
|
|
Phytocannabinoids (comparison) |
| Cannabibutols |
|
| Cannabichromenes |
|
| Cannabicyclols |
|
| Cannabidiols |
|
| Cannabielsoins |
|
| Cannabigerols |
|
| Cannabiphorols |
|
| Cannabinols |
|
| Cannabitriols |
|
| Cannabivarins |
|
| Delta-8-tetrahydrocannabinols |
|
| Delta-9-tetrahydrocannabinols |
|
| Delta-10-Tetrahydrocannabinols |
|
| Miscellaneous cannabinoids |
|
| Active metabolites |
|
|
| Endocannabinoids |
|
Synthetic cannabinoid receptor agonists / neocannabinoids |
Classical cannabinoids (dibenzopyrans) |
|
Non-classical cannabinoids |
|
| Adamantoylindoles |
|
| Benzimidazoles |
|
| Benzoylindoles |
|
| Cyclohexylphenols |
|
| Eicosanoids |
|
| Hydrocarbons |
|
| Indazole carboxamides |
|
Indazole-3- carboxamides |
|
| Indole-3-carboxamides |
|
| Indole-3-carboxylates |
|
| Naphthoylindazoles |
|
| Naphthoylindoles |
|
| Naphthoylpyrroles |
|
| Naphthylmethylindenes |
|
| Naphthylmethylindoles |
|
| Phenylacetylindoles |
|
| Pyrazolecarboxamides |
|
| Pyrrolobenzoxazines |
|
| Quinolinyl esters |
|
Tetramethylcyclo- propanoylindazoles |
|
Tetramethylcyclo- propanoylindoles |
|
Tetramethylcyclo- propylindoles |
|
| Others |
|
|
|
Allosteric CBR ligands
|
|
Endocannabinoid enhancers (inactivation inhibitors)
|
|
Anticannabinoids (antagonists/inverse agonists/antibodies)
|
|
|